Evidence map›Paper›PMID 31929860›Full record

ArticleInternational journal of preventive medicine2019

Effects of Selenium Supplementation on Cardiometabolic Risk Factors, Inflammatory, and Antioxidant Markers: A Systematic Review and Meta-analysis Protocol.

Shirin Djalalinia, Mahnoosh Khosravi, Motahareh Hasani, Sahar Saeedi Moghaddam, Mehrdad Kazemzadeh Atoofi, Armita Mahdavi-Gorabi, Mehdi Noroozi, Mostafa Qorbani, Hamid Asayesh, Ali Soleimani

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of preventive medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Shirin DjalaliniaDeputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran.
Mahnoosh KhosraviDeputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran.
Motahareh HasaniDepartment of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
Sahar Saeedi MoghaddamNoncommunicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Mehrdad Kazemzadeh AtoofiSpiritual Health Research Center, School of Behavioral Sciences and Mental Health, Tehran Psychiatric Institute, Iran University of Medical Sciences, Tehran, Iran.
Armita Mahdavi-GorabiDepartment of Basic and Clinical Research, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Mehdi NorooziSocial Determinants of Health Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Mostafa QorbaniNon-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Hamid AsayeshDepartment of Medical Emergencies, Qom University of Medical Sciences, Qom, Iran.
Ali SoleimaniDepartment of Public Health, Maragheh University of medical Sciences, Maragheh, Iran.
Iran University of Medical Sciences · IRJahrom University of Medical Sciences · IRMinistry of Health and Medical Education · IRShahid Beheshti University of Medical Sciences · IRUniversity of Maragheh · IRUniversity of Social Welfare and Rehabilitation Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSelenium (Se) is considered as an antioxidant trace element involved in key activities in human metabolism. Recent investigations indicate that Se plays a pivotal role in human health. Se supplementation considered as an intervention is both cost-effective and simple-to-use that may play an important role in the prevention of cardiometabolic risk factors (CRFs), inflammatory, and antioxidant markers.

methodsThis paper is a protocol study on systematic review of probable effects of Se supplementation on CRFs, inflammatory, and antioxidant markers. The aim was to achieve three international databases available related to the current publications including, PubMed, ISI/WOS, and Scopus. We attempted to search for randomized clinical trials (RCT) and cross-over trials pertaining to human subjects without any restriction on language and time. In addition, there was no limitation on the age of participants. For RCTs were included all studies in different target groups comprising diabetic patients, patients with polycystic ovarian syndrome, obese subjects, or even healthy controls. To investigate the effect of Se, we included all studies which Se is used either as single therapy or as combination therapy. All studies associated with articles and meta-analyses would be evaluated to review their references.

conclusionsThe current study contained numerous outcomes. The result of this study can be led to make reliable scientific evidence on the probable effects of Se supplementation on CRFs, inflammatory factors, and antioxidant factors. In addition to these findings, other technical documents developed for a systematic review can be used for future studies.

Indexed as

Antioxidant markerscardiometabolic risk factorsinflammatory markersseleniumsupplementationsystematic review

Identifiers

PMID31929860
PMCPMC6941376
OpenAlexW2999268790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.